Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims Study
While direct costs over 24 months were higher in patients initiating GMB for migraine prevention, better adherence and longer treatment duration with GMB regardless of gender or migraine type support the use of GMB compared with SOC.
Authors
- Gayle Allenback (ORCID: https://orcid.org/0000-0002-9948-1750)
- Gilwan Kim (ORCID: https://orcid.org/0000-0003-1991-6644)
- Margaret Hoyt (ORCID: https://orcid.org/0000-0002-9486-2095)
- Michelle Vu (ORCID: https://orcid.org/0000-0003-0795-1688)
- Oralee J. Varnado (ORCID: https://orcid.org/0000-0001-8054-2544)
- Helen Trenz
- Erin Buysman (ORCID: https://orcid.org/0000-0003-0104-5836)
- Lars Viktrup (ORCID: https://orcid.org/0000-0002-8739-0544)
- Feng Cao (ORCID: https://orcid.org/0000-0002-1010-6429)
Institutions
- Eli Lilly (United States) (US)
- Optum (United States) (US)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/ppa.s492300
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00